Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Switching ART to a more lipid-friendly regimen may be a reasonable approach in patients who are unable to achieve desired lipid goals through other means
    • This strategy is best undertaken in patients on an initial regimen, where lipid derangement is considered largely due to ART

  • Switching NRTIsSwitching to an NNRTI
      Switching to an Integrase or CCR5 Inhibitor
        Summary

        Action required